TR199902508T2 - HIV proteaz inhibit�rleri. - Google Patents

HIV proteaz inhibit�rleri.

Info

Publication number
TR199902508T2
TR199902508T2 TR1999/02508T TR9902508T TR199902508T2 TR 199902508 T2 TR199902508 T2 TR 199902508T2 TR 1999/02508 T TR1999/02508 T TR 1999/02508T TR 9902508 T TR9902508 T TR 9902508T TR 199902508 T2 TR199902508 T2 TR 199902508T2
Authority
TR
Turkey
Prior art keywords
hiv protease
hiv
protease inhibitors
compounds
virus
Prior art date
Application number
TR1999/02508T
Other languages
English (en)
Turkish (tr)
Inventor
F. Albizati Kim
Reich Siegfried
D. Varney Michael
E. Zhang Kanyin
Kobayshi Takuo
Original Assignee
Agouron Pharmaceuticals, Inc.
Japan Tobacco Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals, Inc., Japan Tobacco Inc. filed Critical Agouron Pharmaceuticals, Inc.
Publication of TR199902508T2 publication Critical patent/TR199902508T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
TR1999/02508T 1997-03-13 1998-03-12 HIV proteaz inhibit�rleri. TR199902508T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81595197A 1997-03-13 1997-03-13

Publications (1)

Publication Number Publication Date
TR199902508T2 true TR199902508T2 (xx) 2000-02-21

Family

ID=25219265

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/02508T TR199902508T2 (xx) 1997-03-13 1998-03-12 HIV proteaz inhibit�rleri.

Country Status (35)

Country Link
EP (1) EP0970055A2 (sk)
JP (1) JP2001516350A (sk)
KR (1) KR100511089B1 (sk)
CN (1) CN1179948C (sk)
AP (1) AP1358A (sk)
AR (1) AR012556A1 (sk)
AU (1) AU743078B2 (sk)
BG (1) BG63540B1 (sk)
BR (1) BR9808867A (sk)
CA (1) CA2284163A1 (sk)
CO (1) CO4940496A1 (sk)
CZ (1) CZ296647B6 (sk)
EA (1) EA002378B1 (sk)
EE (1) EE04114B1 (sk)
GE (1) GEP20022764B (sk)
HR (1) HRP980112A2 (sk)
HU (1) HUP0001380A3 (sk)
IL (2) IL131870A0 (sk)
IS (1) IS5176A (sk)
MX (1) MXPA99008395A (sk)
MY (1) MY117535A (sk)
NO (1) NO315555B1 (sk)
NZ (1) NZ337706A (sk)
OA (1) OA11196A (sk)
PA (1) PA8448801A1 (sk)
PE (1) PE58799A1 (sk)
PL (1) PL192786B1 (sk)
SA (1) SA98181116B1 (sk)
SK (1) SK283636B6 (sk)
SV (1) SV1998000038A (sk)
TR (1) TR199902508T2 (sk)
TW (1) TW200517112A (sk)
UA (1) UA57772C2 (sk)
WO (1) WO1998040357A2 (sk)
ZA (1) ZA982047B (sk)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
HUP0001380A2 (hu) 2000-09-28
NO994415D0 (no) 1999-09-10
PL192786B1 (pl) 2006-12-29
CZ319199A3 (cs) 2000-06-14
JP2001516350A (ja) 2001-09-25
OA11196A (en) 2003-05-21
IL131870A0 (en) 2001-03-19
EE04114B1 (et) 2003-08-15
PE58799A1 (es) 1999-07-12
EA002378B1 (ru) 2002-04-25
IS5176A (is) 1999-09-10
AP9901648A0 (en) 1999-09-30
MXPA99008395A (es) 2003-08-12
AR012556A1 (es) 2000-11-08
PL335672A1 (en) 2000-05-08
BG103727A (en) 2000-04-28
BG63540B1 (bg) 2002-04-30
AU743078B2 (en) 2002-01-17
NZ337706A (en) 2001-04-27
SA98181116B1 (ar) 2006-10-04
WO1998040357A3 (en) 1998-11-26
KR20000076236A (ko) 2000-12-26
IL131870A (en) 2006-04-10
EA199900823A1 (ru) 2000-04-24
PA8448801A1 (es) 2000-05-24
NO315555B1 (no) 2003-09-22
ZA982047B (en) 1998-09-28
EP0970055A2 (en) 2000-01-12
NO994415L (no) 1999-11-10
CA2284163A1 (en) 1998-09-17
GEP20022764B (en) 2002-08-26
CO4940496A1 (es) 2000-07-24
UA57772C2 (uk) 2003-07-15
HRP980112A2 (en) 1998-12-31
TW200517112A (en) 2005-06-01
BR9808867A (pt) 2000-07-11
CN1179948C (zh) 2004-12-15
MY117535A (en) 2004-07-31
CN1253548A (zh) 2000-05-17
SK283636B6 (sk) 2003-11-04
KR100511089B1 (ko) 2005-08-31
AP1358A (en) 2004-12-03
EE9900416A (et) 2000-04-17
AU6457598A (en) 1998-09-29
SK122299A3 (en) 2000-05-16
WO1998040357A2 (en) 1998-09-17
HUP0001380A3 (en) 2001-12-28
SV1998000038A (es) 1999-02-15
CZ296647B6 (cs) 2006-05-17

Similar Documents

Publication Publication Date Title
MY138860A (en) Hiv protease inhibitors.
TR200401314T2 (tr) Sübstitüe edilmiş oksazolidinonlar ve bunların kullanımı
EA199901031A1 (ru) Производные бензимидазола
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
ATE196288T1 (de) N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren
EA200400026A1 (ru) Ингибиторы вич-протеазы, содержащие их композиции, их фармацевтические применения и вещества для их синтеза
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
TR200202528T2 (tr) Aspartil proteaz inhibitörleri
ATE217871T1 (de) 5,6-dihydropyron derivate als protease inhibitoren und antivirusmitteln
ES2132383T3 (es) Inhibidores de proteasa hiv.
ATE245444T1 (de) Pharmazeutische zusammensetzung, enthaltend peg- asparaginase, für die behandlung von hiv infektionen
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
TR200003797T2 (tr) Alfa-D-ksiloz'dan türetilen yeni terkipler, bunların hazırlanma yöntemleri ve tedavi maksatlı kullanımları.
TR199902508T2 (xx) HIV proteaz inhibit�rleri.
EE9900188A (et) HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread
IT1318424B1 (it) Composti con attivita' anti-hiv.
TR200102019T2 (tr) 3-izoksazolidinonların ve hidroksilamik asitlerin enfeksiyonların tedavisinde kullanılmaları.
DE69426574D1 (de) Makrocyclische difluorostatonderivate als antivirale mittel
TH14264B (th) ตัวยับยั้ง hiv โพรทิเอส
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )